Merck & Company, Inc. Price Today
Merck & Company, Inc.
MRK
Healthcare
$320.53B
💰
Market Cap
904.0
💸
Price to Earnings
$0.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
17 |
Strong Buy |
10 |
Hold |
5 |
Sell |
0 |
Strong Sell |
0 |
MRK Price Forecast Target
126.6 👉 148.0 +17%
MRK EPS Forecast
0.1 👉 9.8 +6886%
Financials
Profit Margin
1 %
Revenue Growth
5.8 %
Dividend
$ 3.08
Held Percent
0.1% - Insiders
78.6% - Institutions
21.3% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
George Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the world…
Ron Baron Portfolio
Ron Baron is an American billionaire investor, entrepreneur, and the founder of Baron Capital Group, a well-known investment management firm. He is recognized for his long-term, growth-oriented investment approach and has built a successful track re…
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…
Christopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wi…📮FAQ
Some Frequently Asked Questions.
The Merck & Company, Inc. industry is Drug Manufacturers—General
The Merck & Company, Inc. sector is Healthcare
The Merck & Company, Inc. forecasted predicted Price to Earnings PE ratio is 12.9
The Merck & Company, Inc. Price to Earnings PE ratio is 904.0
The Market Capitalization of Merck & Company, Inc. is $320.53B
There are total of 2527831849 float shares with 78.6% held by Institutions and 0.1% held by insiders
The MMerck & Company, Inc. forecasted Earnings per Share EPS is $9.8
The Merck & Company, Inc. Earnings per Share EPS is 0.1
The Merck & Company, Inc. company has $0 gross profits with 1 profit margins
The Merck & Company, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Merck & Company, Inc. Revenue is $60115001344 with 0.058 revenue growth
The price target for Merck & Company, Inc. stock is $148.0 for the high target and $118.0 for the low target
The consensus analyst recommendations for Merck & Company, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Merck & Company, Inc. is Buy, with the following breakdown:
- Buy: 17
- Strong Buy: 10
- Hold: 5
- Sell: 0
- Strong Sell: 0
The Beta of Merck & Company, Inc. is 0.4
The dividend of Merck & Company, Inc. is $3.08
The dividend yield of Merck & Company, Inc. is 0.024300002%
The biggest institutional and mutual fund holders of Merck & Company, Inc. stock are
The Merck & Company, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0